جستجو
   
    Delicious RSS ارسال به دوستان خروجی متنی
    کد خبر : 186719
    تاریخ انتشار : 26 تیر 1395 11:6
    تعداد بازدید : 1042

    American journal of law and medicine

    American journal of law and medicine

    2000,  Vol.26               2010,  Vol.36

    2001,  Vol.27               2011,  Vol.37

    2002,  Vol.28               2012,  Vol.38

    2003,  Vol.29               2013,  Vol.39

    2004,  Vol.30               2014,  Vol.40

    2005,  Vol.31               2015,  Vol.41

    2006,  Vol.32

    2007,  Vol.33

    2008,  Vol.34

    2009,  Vol.35

     

    American journal of law and medicine, 2000,  Vol.26

    Author

    Title

    number

    Page to Page

    Clark C. Havighurst

    VICARIOUS LIABILITY: RELOCATING RESPONSIBILITY FOR THE QUALITY OF MEDICAL CARE

     No.1

     pp. 7-29

    Hrobjartur Jonatansson

    ICELAND'S HEALTH SECTOR DATABASE: A SIGNIFICANT HEAD START IN THE SEARCH FOR THE BIOLOGICAL GRAIL OR AN IRREVERSIBLE ERROR?

     No.1

     pp. 31-67

    Kathleen A. Peterson

    FIRST NURSING HOMES, NEXT MANAGED CARE?: LIMITING LIABILITY IN QUALITY OF CARE CASES UNDER THE FALSE CLAIMS ACT

     No.1

     pp. 69-88

    Tiffany F. Theodos

    THE PATIENTS' BILL OF RIGHTS: WOMEN'S RIGHTS UNDER MANAGED CARE AND ERISA PREEMPTION

     No.1

     pp. 89-108

    David A. Hyman

    MEDICINE IN THE NEW MILLENNIUM: A SELF- HELP GUIDE FOR THE PERPLEXED

     No.2-3

     pp. 143-154

    Peter D. Jacobson, Michael T. Cahill

    APPLYING FIDUCIARY RESPONSIBILITIES IN THE MANAGED CARE CONTEXT

     No.2-3

     pp. 155-173

    Timothy S. Jost

    THE GLOBALIZATION OF HEALTH LAW: THE CASE OF PERMISSIBILITY OF PLACEBO- BASED RESEARCH

     No.2-3

     pp. 175-186

    Arthur B. LaFrance

    TOBACCO LITIGATION: SMOKE, MIRRORS AND PUBLIC POLICY

     No.2-3

     pp. 187-203

    Sylvia A. Law

    HEALTH CARE IN HAWAI'I: AN AGENDA FOR RESEARCH AND REFORM

     No.2-3

     pp. 205-223

    Theodore R. Marmor, Gary J. McKissick

    MEDICARE'S FUTURE: FACT, FICTION AND FOLLY

     No.2-3

     pp. 225-253

    Ross D. Silverman

    REGULATING MEDICAL PRACTICE IN THE CYBER AGE: ISSUES AND CHALLENGES FOR STATE MEDICAL BOARDS

     No.2-3

     pp. 255-276

    Kenneth R. Wing

    HEALTH CARE REFORM IN THE YEAR 2000: THE VIEW FROM THE FRONT OF THE CLASSROOM

     No.2-3

     pp. 277-293

    Kristen J. Josefek

    ALTERNATIVE MEDICINE'S ROADMAP TO MAINSTREAM

     No.2-3

     pp. 295-310

    Eleanor D. Kinney

    TAPPING AND RESOLVING CONSUMER CONCERNS ABOUT HEALTH CARE

     No.4

     pp. 335-399

    Narbeh Bagdasarian

    A PRESCRIPTION FOR MENTAL DISTRESS: THE PRINCIPLES OF PSYCHOSOMATIC MEDICINE WITH THE PHYSICAL MANIFESTATION REQUIREMENT IN N.I.E.D. CASES

     No.4

     pp. 401-438

    Allyson R. Behm

    THE AMERICANS WITH (OR WITHOUT) DISABILITIES ACT: PRE- EMPLOYMENT MEDICAL INQUIRIES AND THE NON- DISABLED

     No.4

     pp. 439-452

    Sharon J. Hussong

    MEDICAL RECORDS AND YOUR PRIVACY: DEVELOPING FEDERAL LEGISLATION TO PROTECT PATIENT PRIVACY RIGHTS

     No.4

     pp. 453-474

    John Larkin Thompson

    MEDICARE PLAY- BY- PLAY: A REVIEW OF THEODORE MARMOR'S 'THE POLITICS OF MEDICARE'

     No.4

     pp. 475-478

    American journal of law and medicine, 2001,  Vol.27

    Author

    Title

    number

    Page to Page

    Alain C. Enthoven, Helen H. Schauffler, Sara McMenamin

    CONSUMER CHOICE AND THE MANAGED CARE BACKLASH

     No.1

     pp. 1-15

    Andrew I. Batavia

    A RIGHT TO PERSONAL ASSISTANCE SERVICES: "MOST INTEGRATED SETTING APPROPRIATE" REQUIREMENTS AND THE INDEPENDENT LIVING MODEL OF LONG-TERM CARE

     No.1

     pp. 17-43

    Penney Lewis

    RIGHTS DISCOURSE AND ASSISTED SUICIDE

     No.1

     pp. 45-99

    Christine Willgoos

    FDA REGULATION: AN ANSWER TO THE QUESTIONS OF HUMAN CLONING AND GERMLINE GENE THERAPY

     No.1

     pp. 101-124

    Jerome P. Kassirer

    FINANCIAL CONFLICT OF INTEREST: AN UNRESOLVED ETHICAL FRONTIER

     No.2-3

     pp. 149-162

    Stephen R. Latham

    SYSTEM AND RESPONSIBILITY: THREE READINGS OF THE IOM REPORT ON MEDICAL ERROR

     No.2-3

     pp. 163-179

    Joan H. Krause

    MEDICAL ERROR AS FALSE CLAIM

     No.2-3

     pp. 181-201

    Sidney D. Watson

    RACE, ETHNICITY AND QUALITY OF CARE: INEQUALITIES AND INCENTIVES

     No.2-3

     pp. 203-224

    David M. Studdert, Troyen A. Brennan

    TOWARD A WORKABLE MODEL OF "NO- FAULT" COMPENSATION FOR MEDICAL INJURY IN THE UNITED STATES

     No.2-3

     pp. 225-252

    Michael Baram

    MAKING CLINICAL TRIALS SAFER FOR HUMAN SUBJECTS

     No.2-3

     pp. 253-282

    Fritz H. Bach, Adrian J. Ivinson, H. E. Judge Christopher Weeramantry

    ETHICAL AND LEGAL ISSUES IN TECHNOLOGY: XENOTRANSPLANTATION

     No.2-3

     pp. 283-300

    Tony R. Maida

    HOW JUDICIAL MYOPIA IS JEOPARDIZING THE PROTECTION OF PEOPLE WITH HIV/ AIDS UNDER THE ADA

     No.2-3

     pp. 301-327

    Peter J. Van Hemel

    A WAY OUT OF THE MAZE: FEDERAL AGENCY PREEMPTION OF STATE LICENSING AND REGULATION OF COMPLEMENTARY AND ALTERNATIVE MEDICINE PRACTITIIONERS

     No.2-3

     pp. 329-344

    Nicolas P. Terry

    AN eHEALTH DIPTYCH: THE IMPACT OF PRIVACY REGULATION ON MEDICAL ERROR AND MALPRACTICE LITIGATION

     No.4

     pp. 361-419

    Michael T. Cahill, Peter D. Jacobson

    PEGRAM's REGRESS: A MISSED CHANCE FOR SENSIBLE JUDICIAL REVIEW OF MANAGED CARE DECISIONS

     No.4

     pp. 421-438

    Dayna Bowen Matthew

    AN ECONOMIC MODEL TO ANALYZE THE IMPACT OF FALSE CLAIMS ACT CASES ON ACCESS TO HEALTHCARE FOR THE ELDERLY, DISABLED, RURAL AND INNER- CITY POOR

     No.4

     pp. 439-467

    Andrea M. Curti

    THE WTO DISPUTE SETTLEMENT UNDERSTANDING: AN UNLIKELY WEAPON IN THE FIGHT AGAINST AIDS

     No.4

     pp. 469-485

    American journal of law and medicine, 2002,  Vol.28

    Author

    Title

    number

    Page to Page

    Jennifer S. Geetter

    CODING FOR CHANGE: THE POWER OF THE HUMAN GENOME TO TRANSFORM THE AMERICAN HEALTH INSURANCE SYSTEM

     No.1

     pp. 1-76

    Charlotte H. Harrison

    NEITHER MOORE NOR THE MARKET: ALTERNATIVE MODELS FOR COMPENSATING CONTRIBUTORS OF HUMAN TISSUE

     No.1

     pp. 77-105

    Catherine Olender

    CAPPING AIDS BENEFITS: DOES TITLE III OF THE ADA REGULATE THE CONTENT OF INSURANCE POLICIES?

     No.1

     pp. 107-123

    Patricia A. Roche

    THE GENETIC REVOLUTION AT WORK: LEGISLATIVE EFFORTS TO PROTECT EMPLOYEES

     No.2-3

     pp. 271-283

    Joanne L. Hustead, Janlori Goldman

    GENETICS AND PRIVACY

     No.2-3

     pp. 285-307

    Jennifer Kulynych, David Korn

    USE AND DISCLOSURE OF HEALTH INFORMATION IN GENETIC RESEARCH: WEIGHING THE IMPACT OF THE NEW FEDERAL MEDICAL PRIVACY RULE

     No.2-3

     pp. 309-324

    Ruth K. Miller

    INFORMED CONSENT IN THE MILITARY: FIGHTNG A LOSING BATTLE AGAINST THE ANTHRAX VACCINE

     No.2-3

     pp. 325-343

    George J. Annas, Lori B. Andrews, Rosario M. Isasi

    PROTECTING THE ENDANGERED HUMAN: TOWARD AN INTERNATIONAL TREATY PROHIBITING CLONING AND INHERITABLE ALTERATIONS

     No.2-3

     pp. 151-178

    Maxwell J. Mehlman, Kirsten M. Rabe

    ANY DNA TO DECLARE? REGULATING OFFSHORE ACCESS TO GENETIC ENHANCEMENT

     No.2-3

     pp. 179-213

    Mary R. Anderlik, Mark A. Rothstein

    DNA- BASED IDENTITY TESTING AND THE FUTURE OF THE FAMILY: A RESEARCH AGENDA

     No.2-3

     pp. 215-232

    Sonia Mateu Suter

    THE ROUTINIZAT1ON OF PRENATAL TESTING

     No.2-3

     pp. 233-270

    Lars Noah

    INFORMED CONSENT AND THE ELUSIVE DICHOTOMY BETWEEN STANDARD AND EXPERIMENTAL THERAPY

     No.4

     pp. 361-408

    Rhonda Gay Hartman

    COMING OF AGE: DEVISING LEGISLATION FOR ADOLESCENT MEDICAL DECISION-MAKING

     No.4

     pp. 409-453

    Christine Vargas

    THE EPICC QUEST FOR PRESCRIPTION CONTRACEPTIVE INSURANCE COVERAGE

     No.4

     pp. 455-471

    Laura A. Nicholson

    ADOPTION MEDICINE AND THE INTERNATIONALLY ADOPTED CHILD

     No.4

     pp. 473-490

    Mary L. Durham

    HOW RESEARCH WILL ADAPT TO HIPAA: A VIEW FROM WITHIN THE HEALTHCARE DELIVERY SYSTEM

     No.4

     pp. 491-502

    American journal of law and medicine, 2003,  Vol.29

    Author

    Title

    number

    Page to Page

    Brannon P. Denning

    THE MAINE Rx PRESCRIPTION DRUG PLAN AND THE DORMANT COMMERCE CLAUSE DOCTRINE: THE CASE OF THE MISSING LINK [AGE]

     No.1

     pp. 7-30

    Roderick T. Chen, Alexandra K. Glazier

    CAN SAME- SEX PARTNERS CONSENT TO ORGAN DONATION?

     No.1

     pp. 31-44

    Rob McStay

    TERMINAL SEDATION: PALLIATIVE CARE FOR INTRACTABLE PAIN, POST GLUCKSBERG AND QUILL

     No.1

     pp. 45-76

    Deborah Hellman

    WHAT MAKES GENETIC DISCRIMINATION EXCEPTIONAL?

     No.1

     pp. 77-116

    Kristin Jenkins Gerrick

    AN INQUIRY INTO UNIONIZING HOME HEALTHCARE WORKERS: BENEFITS FOR WORKERS AND PATIENTS

     No.1

     pp. 117-138

    Joanmarie Ilaria Davoli

    NO ROOM AT THE INN: HOW THE FEDERAL MEDICAID PROGRAM CREATED INEQUITIES IN PSYCHIATRIC HOSPITAL ACCESS FOR THE INDIGENT MENTALLY ILL

     No.2-3

     pp. 159-183

    John V. Jacobi

    PARITY AND DIFFERENCE: THE VALUE OF PARITY LEGISLATION FOR THE SERIOUSLY MENTALLY ILL

     No.2-3

     pp. 185-201

    Ana I. Balsa, Naomi Seiler, Thomas G. McGuire, M. Gregg Bloche

    CLINICAL UNCERTAINTY AND HEALTHCARE DISPARITIES

     No.2-3

     pp. 203-219

    Barbara A. Noah

    THE PARTICIPATION OF UNDERREPRESENTED MINORITIES IN CLINICAL RESEARCH

     No.2-3

     pp. 221-245

    Steven P. Wallace, Valentine M. Villa

    EQUITABLE HEALTH SYSTEMS: CULTURAL AND STRUCTURAL ISSUES FOR LATINO ELDERS

     No.2-3

     pp. 247-267

    Janna C. Merrick

    SPIRITUAL HEALING, SICK KIDS AND THE LAW: INEQUITIES IN THE AMERICAN HEALTHCARE SYSTEM

     No.2-3

     pp. 269-299

    Michelle Oberman, Joel Frader

    DYING CHILDREN AND MEDICAL RESEARCH: ACCESS TO CLINICAL TRIALS AS BENEFIT AND BURDEN

     No.2-3

     pp. 301-317

    Lainie Friedman Ross, Catherine Walsh

    MINORITY CHILDREN IN PEDIATRIC RESEARCH

     No.2-3

     pp. 319-336

    Robin Fretwell Wilson

    UNCOVERING THE RATIONALE FOR REQUIRING INFERTILITY IN SURROGACY ARRANGEMENTS

     No.2-3

     pp. 337-362

    Mary Anne Bobinski

    HEALTH DISPARITIES AND THE LAW: WRONGS IN SEARCH OF A RIGHT

     No.2-3

     pp. 363-380

    Joel Teitelbaum, Sara Rosenbaum

    MEDICAL CARE AS A PUBLIC ACCOMMODATION: MOVING THE DISCUSSION TO RACE

     No.2-3

     pp. 381-394

    Louise G. Trubek, Maya Das

    ACHIEVING EQUALITY: HEALTHCARE GOVERNANCE IN TRANSITION

     No.2-3

     pp. 395-421

    John A. Robertson

    PROCREATIVE LIBERTY IN THE ERA OF GENOMICS

     No.4

     pp. 439-487

    Brent Pollitt

    FOOL'S GOLD: PSYCHOLOGISTS USING DISINGENUOUS REASONING TO MISLEAD LEGISLATURES INTO GRANTING PSYCHOLOGISTS PRESCRIPTIVE AUTHORITY

     No.4

     pp. 489-524

    Merri C. Moken

    FAKE PHARMACEUTICALS: HOW THEY AND RELEVANT LEGISLATION OR LACK THEREOF CONTRIBUTE TO CONSISTENTLY HIGH AND INCREASING DRUG PRICES

     No.4

     pp. 525-542

    American journal of law and medicine, 2004,  Vol.30

    Author

    Title

    number

    Page to Page

    John A. Robertson

    PROCREATIVE LIBERTY AND HARM TO OFFSPRING IN ASSISTED REPRODUCTION

     No.1

     pp. 7-40

    Kate Haas

    WHO WILL MAKE ROOM FOR THE INTERSEXED?

     No.1

     pp. 41-68

    Edwin Caldie

    MEDIGAP: SHOULD PRIVATE INSURERS PAY PUBLIC RATES AND WHO SHOULD MAKE THE DECISION?

     No.1

     pp. 69-83

    Guillermo A. Montero

    IF ROTH WERE A DOCTOR: PHYSICIAN REPUTATION UNDER THE HCQIA

     No.1

     pp. 85-100

    Wendy Wagner, David Michaels

    EQUAL TREATMENT FOR REGULATORY SCIENCE: EXTENDING THE CONTROLS GOVERNING THE QUALITY OF PUBLIC RESEARCH TO PRIVATE RESEARCH

     No.2-3

     pp. 119-154

    Jay D. Wexler

    Parks as Gyms? Recreational Paradigms and Public Health in the National Parks

     No.2-3

     pp. 155-188

    Richard W. Ciapp, David Ozonoff

    Environment and Health: Vital Intersection or Contested Territory?

     No.2-3

     pp. 189-215

    Victoria Sutton

    Environment and Public Health in a Time of Plague

     No.2-3

     pp. 217-236

    Gale Norton, Michael Suk

    America's Public Lands and Waters: The Gateway to Better Health?

     No.2-3

     pp. 237-243

    Pamela D. Harvey, C. Mark Smith

    THE MERCURY'S FALLING: THE MASSACHUSETTS APPROACH TO REDUCING MERCURY IN THE ENVIRONMENT

     No.2-3

     pp. 245-281

    Sumudu Attapatu

    THE PUBLIC HEALTH IMPACT OF GLOBAL ENVIRONMENTAL PROBLEMS AND THE ROLE OF INTERNATIONAL LAW

     No.2-3

     pp. 283-304

    Devra Lee Davis, Carrie Forrester

    PAST AND PRESENT ENVIRONMENTAL HEALTH CHALLENGES IN SOUTHWESTERN PENNSYLVANIA: SOME COMMENTS ON THE RIGHT TO A CLEAN ENVIRONMENT

     No.2-3

     pp. 305-332

    Robert R. Kuehn

    Suppression of Environmental Science

     No.2-3

     pp. 333-369

    Rebecca M. Bratspies

    Consuming (F) ears of Corn: Public Health and Biopharming

     No.2-3

     pp. 371-404

    Benjamin Mason Meier

    INTERNATIONAL CRIMINAL PROSECUTION OF PHYSICIANS: A CRITIQUE OF PROFESSORS ANNAS AND GRODIN'S PROPOSED INTERNATIONAL MEDICAL TRIBUNAL

     No.4

     pp. 419-452

    Daniel Sperling

    MATERNAL BRAIN DEATH

     No.4

     pp. 453-500

    Bryan A. Liang, LiLan Ren

    MEDICAL LIABILITY INSURANCE AND DAMAGE CAPS: GETTING BEYOND BAND AIDS TO SUBSTANTIVE SYSTEMS TREATMENT TO IMPROVE QUALITY AND SAFETY IN HEALTHCARE

     No.4

     pp. 501-541

    Brian Thompson

    THE OBESITY AGENCY: CENTRALIZING THE NATION'S FIGHT AGAINST FAT

     No.4

     pp. 543-559

    American journal of law and medicine, 2005,  Vol.31

    Author

    Title

    number

    Page to Page

    Rhonda Gay Hartman

    Face Value: Challenges of Transplant Technology

     No.1

     pp. 7-46

    Angela Campbell

    Ethos and Economics: Examining the Rationale Underlying Stem Cell and Cloning Research Policies in the United States, Germany, and Japan

     No.1

     pp. 47-86

    Samuel J. Tilden

    Ethical and Legal Aspects of Using an Identical Twin as a Skin Transplant Donor for a Severely Burned Minor

     No.1

     pp. 87-116

    Christine C. Kung

    Defining a Standard of Care in the Practice of Acupuncture

     No.1

     pp. 117-130

    Barbara A. Noah

    FOREWORD: DIETARY SUPPLEMENT REGULATION IN FLUX

     No.2-3

     pp. 147-153

    Peter Barton Hutt

    FDA STATUTORY AUTHORITY TO REGULATE THE SAFETY OF DIETARY SUPPLEMENTS

     No.2-3

     pp. 155-174

    Peter J. Cohen

    SCIENCE, POLITICS, AND THE REGULATION OF DIETARY SUPPLEMENTS: IT'S TIME TO REPEAL DSHEA

     No.2-3

     pp. 175-214

    Michael A. McCann

    DIETARY SUPPLEMENT LABELING: COGNITIVE BIASES, MARKET MANIPULATION & CONSUMER CHOICE

     No.2-3

     pp. 215-268

    Dana Ziker

    WHAT LIES BENEATH: AN EXAMINATION OF THE UNDERPINNINGS OF DIETARY SUPPLEMENT SAFETY REGULATION

     No.2-3

     pp. 269-284

    Scott Bass, Emily Marden

    THE NEW DIETARY INGREDIENT SAFETY PROVISION OF DSHEA: A RETURN TO CONGRESSIONAL INTENT

     No.2-3

     pp. 285-304

    Martin Hahn How

    FUNCTIONAL FOODS: WHAT ARE THEY? ARE THEY REGULATED? WHAT CLAIMS CAN BE MADE?

     No.2-3

     pp. 305-340

    Suzan Onel

    DIETARY SUPPLEMENTS: A DEFINITION THAT IS BLACK, WHITE, AND GRAY

     No.2-3

     pp. 341-348

    Maxwell J. Mehlman

    QUACKERY

     No.2-3

     pp. 349-363

    David Loughnot

    POTENTIAL INTERACTIONS OF THE ORPHAN DRUG ACT AND PHARMACOGENOMICS: A FLOOD OF ORPHAN DRUGS AND ABUSES?

     No.2-3

     pp. 365-380

    Timothy S. Jost, Mark A. Hall

    The Role of State Regulation in Consumer Driven Health Care

     No.4

     pp. 395-418

    Alicia Ouellette, Arthur Caplan, Kelley Carroll, James W. Fossett, Dyrleif Bjarnadottir, Darren Shickle, Glenn McGee

    LESSONS ACROSS THE POND: ASSISTED REPRODUCTIVE TECHNOLOGY IN THE UNITED KINGDOM AND THE UNITED STATES

     No.4

     pp. 419-446

    John V. Jacobi

    PRISON HEALTH, PUBLIC HEALTH: OBLIGATIONS AND OPPORTUNITIES

     No.4

     pp. 447-478

    Matthew E. Brown

    REDEFINING THE PHYSICIAN SELECTION PROCESS AND REWRITING MEDICAL MALPRACTICE SETTLEMENT DISCLOSURE WEBPAGES

     No.4

     pp. 479-507

    Kirath Raj

    The Presidents' Mental Health

     No.4

     pp. 509-524

    American journal of law and medicine, 2006,  Vol.32

    Author

    Title

    number

    Page to Page

    Thomas R. McLean

    International Law, Telemedicine and Health Insurance: China as a Case Study

     No.1

     pp. 7-51

    Stella L. Smetanka

    Who Will Protect the "Disruptive" Dialysis Patient?

     No.1

     pp. 53-91

    Ben J. Kusmin

    Swing Low, Sweet Chariot: Abandoning the Disinterested Witness Requirement for Advance Directives

     No.1

     pp. 93-116

    Kelly A. Gabos

    The Perils of Singleton v. Norris: Ethics and Beyond

     No.1

     pp. 117-132

    Kevin Outterson

    PATENT BUY- OUTS FOR GLOBAL DISEASE INNOVATIONS FOR LOW AND MIDDLE-INCOME COUNTRIES

     No.2-3

     pp. 159-173

    John A. Vernon, Joseph H. Golec, W. Keener Hughen

    THE ECONOMICS OF PHARMACEUTICAL PRICE REGULATION AND IMPORTATION REFOCUSING THE DEBATE

     No.2-3

     pp. 175-192

    Aidan Hollis, Peter Ibbott

    HOW PARALLEL TRADE AFFECTS DRUG POLICIES AND PRICES IN CANADA AND THE UNITED STATES

     No.2-3

     pp. 193-217

    Mary Ellen Fleck Kleiman

    STATE REGULATION OF CANADIAN PHARMACIES: A PRESCRIPTION TO VIOLATE THE SUPREMACY CLAUSE

     No.2-3

     pp. 219-246

    Daniel Gilman

    OY CANADA! TRADE'S NON- SOLUTION TO "THE PROBLEM" OF U.S. DRUG PRICES

     No.2-3

     pp. 247-277

    Bryan A. Liang

    FADE TO BLACK: IMPORTATION AND COUNTERFEIT DRUGS

     No.2-3

     pp. 279-323

    Donald deKieffe

    TROJAN DRUGS: COUNTERFEIT AND MISLABELED PHARMACEUTICALS IN THE LEGITIMATE MARKET

     No.2-3

     pp. 325-349

    Robert Gatter

    CONFLICTS OF INTEREST IN INTERNATIONAL HUMAN DRUG RESEARCH AND THE INSUFFICIENCY OF INTERNATIONAL PROTECTIONS

     No.2-3

     pp. 351-364

    W. John Thomas

    THE VlOXX STORY: WOULD IT HAVE ENDED DIFFERENTLY IN THE EUROPEAN UNION?

     No.2-3

     pp. 365-380

    Kevin S. Prussi

    NAFTA AND THE ALLEN TORT CLAIMS ACT: MAKING A CASE FOR THE ACTIONABLE OFFENSES BASED ON ENVIRONMENTAL HARMS AND INJURIES TO THE PUBLIC HEALTH RECENT DEVELOPEMENTS IN HEALTH LAW

     No.2-3

     pp. 381-404

    Jamie Staples King, Benjamin W. Moulton

    Rethinking Informed Consent: The Case for Shared Medical Decision-Making

     No.4

     pp. 429-501

    David R. Katner

    The Mental Health Paradigm and the MacArthur Study: Emerging Issues Challenging the Competence of Juveniles in Delinquency Systems

     No.4

     pp. 503-583

    Carmen E. Lewis

    My Computer, My Doctor: A Constitutional Call for Federal Regulation of Cybermedicine

     No.4

     pp. 585-609

    American journal of law and medicine, 2007,  Vol.33

    Author

    Title

    number

    Page to Page

    Carolyn Jacobs Chachkin

    What Potent Blood: Non- Invasive Prenatal Genetic Diagnosis and the Transformation of Modern Prenatal Care

     No.1

     pp. 9-53

    Stephen W. Smith

    Some Realism about End of Life: The Current Prohibition and the Euthanasia Underground

     No.1

     pp. 55-95

    Ian Jaquette

    Merck KGaA v Integra Lifesciences I, Ltd.: Implications of the Supreme Court's Decision for The People Who Matter Most... The Consumer

     No.1

     pp. 97-117

    Lindsey Singeo

    The Patentability of the Native Hawaiian Genome

     No.1

     pp. 119-139

    George J. Annas

    Foreword: Imagining a New Era of Neuroimaging, Neuroethics, and the Law

     No.2-3

     pp. 163-170

    Laura Stephens Khoshbin, Shahram Khoshbin

    Imaging the Mind, Minding the Image: An Historical Introduction to Brain Imaging and the Law

     No.2-3

     pp. 171-192

    Stacey A. Tovino

    Imaging Body Structure and Mapping Brain Function: An Historical Approach

     No.2-3

     pp. 193-228

    Steven Goldberg

    MRIs and the Perception of Risk

     No.2-3

     pp. 229-237

    Joseph H. Baskin, Judith G. Edersheim, Bruce H. Price

    Is a Picture Worth a Thousand Words? Neuroimaging in the Courtroom

     No.2-3

     pp. 239-269

    Laurence R. Tancredi, Jonathan D. Brodie

    The Brain and Behavior: Limitations in the Legal Use of Functional Magnetic Resonance Imaging

     No.2-3

     pp. 271-294

    Jennifer J. Kulynych

    The Regulation of MR Neuroimaging Research: Disentangling the Gordian Knot

     No.2-3

     pp. 295-317

    Mark Pettit

    FMRI and BF Meet FRE: Brain Imaging and the Federal Rules of Evidence

     No.2-3

     pp. 319-340

    Sean Kevin Thompson

    A Brave New World of Interrogation Jurisprudence?

     No.2-3

     pp. 341-357

    Sarah E. Stoller, Paul Root Wolpe

    Emerging Neurotechnologies for Lie Detection and the Fifth Amendment

     No.2-3

     pp. 359-375

    Henry T. Greely, Judy Illes

    Neuroscience- Based Lie Detection: The Urgent Need for Regulation

     No.2-3

     pp. 377-431

    Adam Kolber

    Pain Detection and the Privacy of Subjective Experience

     No.2-3

     pp. 433-456

    Bruce A. Arrigo

    Punishment, Freedom, and the Culture of Control: The Case of Brain Imaging and the Law

     No.2-3

     pp. 457-482

    Jonathan H. Marks

    Interrogational Neuroimaging in Counterterrorism: A "No- Brainer or a Human Rights Hazard?

     No.2-3

     pp. 483-500

    Abram S. Barth

    A Double- Edged Sword: The Role of Neuroimaging in Federal Capital Sentencing

     No.2-3

     pp. 501-522

    Debora Spar, Anna Harrington

    Selling Stem Cell Science: How Markets Drive the Law along the Technological Frontier

     No.4

     pp. 541-565

    Dov Fox

    Silver Spoons and Golden Genes: Genetic Engineering and the Egalitarian Ethos

     No.4

     pp. 567-623

    Karen Gurney

    Sex and the Surgeon's Knife: The Family Court's Dilemma... Informed Consent and the Specter of Iatrogenic Harm to Children with Intersex Characteristics

     No.4

     pp. 625-661

    Anthony Ten Haagen

    Surviving ERISA Preemption: The Importance of Chapter 58 in the Context of America's Health Care Crisis

     No.4

     pp. 663-682

    Jared Steifel

    ERISA Preemption of Chapter 58: The Future of the "Pay or Play" Model of Health Care Legislation

     No.4

     pp. 683-701

    American journal of law and medicine, 2008,  Vol.34

    Author

    Title

    number

    Page to Page

    Scott Sasjack

    Demanding Individually Safe Drugs Today: Overcoming the Cross- labeling Legal Hurdle to Pharmacogenomics

     No.1

     pp. 7-40

    Robin Fretwell Wilson

    Essay: The Limits of Conscience: Moral Clashes over Deeply Divisive Healthcare Procedures

     No.1

     pp. 41-63

    Tracy Solomon Dowling

    Mandating a Human Papillomavirus Vaccination for School Attendance: An Investigation into Whether Such Legislation is Constitutional and Prudent

     No.1

     pp. 65-84

    Erik Iverson, Regina Rabinovich

    Foreword- Global Access to Health: Legal, Business and Policy Obstacles

     No.2-3

     pp. 97-106

    Graham Dutfield

    Delivering Drugs to the Poor: Will the TRIPS Amendment Help?

     No.2-3

     pp. 107-124

    Aaron S. Kesselheim

    Think Globally, Prescribe Locally: How Rational Pharmaceutical Policy in the U.S. Can Improve Global Access to Essential Medicines

     No.2-3

     pp. 125-139

    Gerald T. Keusch

    When You Reach a Fork in the Road, Take It: Science and Product Development as Linked Paths

     No.2-3

     pp. 141-149

    Peter Drahos

    "Trust Me": Patent Offices in Developing Countries

     No.2-3

     pp. 151-174

    Gail E. Evans

    Strategic Patent Licensing for Public Research Organizations: Deploying Restriction and Reservation Clauses to Promote Medical R&D in Developing Countries

     No.2-3

     pp. 175-223

    Ruth Levine, Jessica Pickett, Neelam Sekhri, Prashant Yadav

    Demand Forecasting for Essential Medical Technologies

     No.2-3

     pp. 225-255

    Jack Lerner

    Intellectual Property and Development at WHO and WIPO

     No.2-3

     pp. 257-277

    Kevin Outterson

    Should Access to Medicines and TRIPS Flexibilities Be Limited to Specific Diseases?

     No.2-3

     pp. 279-301

    Brook K. Baker

    Ending Drug Registration Apartheid: Taming Data Exclusivity and Patent/Registration Linkage

     No.2-3

     pp. 303-344

    Peter K. Yu

    Access to Medicines, BRICS Alliances, and Collective Action

     No.2-3

     pp. 345-394

    Radhika Bhattacharya

    Are Developing Countries Going Too Far on TRIPS? A Closer Look at the New Laws in India

     No.2-3

     pp. 395-421

    Richard S. Saver

    In Tepid Defense of Population Health: Physicians and Antibiotic Resistance

     No.4

     pp. 431-491

    Gil Siegal, Michelle M. Mello, David M. Studdert

    Adjudicating Severe Birth Inquiry Claims in Florida and Virginia: The Experience of a Landmark Experiment in Personal Injury Compensation

     No.4

     pp. 493-537

    Margaret Gilhooley

    Drug Preemption and the Need to Reform the FDA Consultation Process

     No.4

     pp. 539-561

    Paige E. Goodwin

    Right Idea, Wrong Result- Canada's Access to Medicines Regime

     No.4

     pp. 567-584

    American journal of law and medicine, 2009,  Vol.35

    Author

    Title

    number

    Page to Page

    Carl E. Schneider, Mark A. Hall

    The Patient Life: Can Consumers Direct Health Care?

     No.1

     pp. 7-65

    Wendy K. Mariner

    Toward An Architecture of Health Law

     No.1

     pp. 67-87

    Kathleen M. Boozang, Simone Handler-Hutchinson

    "Monitoring" Corporate Corruption: DOJ's Use of Deferred Prosecution Agreements in Health Care

     No.1

     pp. 89-124

    Bryan A. Liang, Tim Mackey

    Searching For Safety: Addressing Search Engine, Website, and Provider Accountability for Illicit Online Drug Sales

     No.1

     pp. 125-184

    Adrianne Ortega

    ...And Health Care for All: Immigrants in the Shadow of the Promise of Universal Health Care

     No.1

     pp. 185-204

    Kaj Rozga

    Retail Health Clinics: How the Next Innovation in Market- Driven Health Care is Testing State and Federal Law

     No.1

     pp. 205-231

     

    Select Recent Court Decisions

     No.1

     pp. 233-240

    Kevin Outterson

    Foreword: Will HPV Vaccines Prevent Cervical Cancers Among Poor Women of Color?: Global Health Policy at the Intersection of Human Rights and Intellectual Property Law

     No.2-3

     pp. 247-252

    Sara E. Crager, Ethan Guillen, Matt Price

    University Contributions to the HPV Vaccine and Implications for Access to Vaccines in Developing Countries: Addressing Materials and Know- How in University Technology Transfer Policy

     No.2-3

     pp. 253-279

    Beirne Roose-Snyder, Megan K. Doyle

    The Global Health Licensing Program: A New Model for Humanitarian Licensing at the University Level

     No.2-3

     pp. 281-309

    Jon Kim Andrus, Ciro de Quadros, Cuauhtemoc Ruiz Matus, Silvana Luciani, & Peter Hotez

    New Vaccines for Developing Countries: Will it be Feast or Famine?

     No.2-3

     pp. 311-322

    Peter Maybarduk, Sarah Rimmington

    Compulsory Licenses: A Tool to Improve Global Access to the HPV Vaccine?

     No.2-3

     pp. 323-350

    Abigail English, Carol A. Ford, John Santelli

    Clinical Preventive Services for Adolescents: Position Paper of the Society for Adolescent Medicine

     No.2-3

     pp. 351-364

    Joanna N. Erdman

    Human Rights in Health Equity: Cervical Cancer and HPV Vaccines

     No.2-3

     pp. 365-387

    Gregory D. Zimet

    Potential Barriers to HPV Immunization: From Public Health to Personal Choice

     No.2-3

     pp. 389-399

    Vivien Davis Tsu

    Overcoming Barriers and Ensuring Access to HPV Vaccines in Low- Income Countries

     No.2-3

     pp. 401-413

    Sean McElligott

    Addressing Supply Side Barriers to Introduction of New Vaccines to the Developing World

     No.2-3

     pp. 415-441

    Katherine M. Sullivan

    But Doctor, I still have Both Feet! Remedial Problems Faced by Victims of Medical Identity Theft

     No.4

     pp. 647-681

    Anne B. Claiborne, Julia R. Hesse, Daniel T. Roble

    Legal Impediments to Implementing Value Based Purchasing in Healthcare

     No.4

     pp. 442-504

    Duncan MacCourt, Joseph Bernstein

    Medical Error Reduction and Tort Reform Through Private Contractually-Based Quality Medicine Societies

     No.4

     pp. 505-561

    Wojciech Baginski

    Hastening Death: Dying, Dignity and the Organ Shortage Gap

     No.4

     pp. 562-584

    Gwendolyn Roberts Majette

    From Concierge Medicine to Patient- Centered Medical Homes: International Lessons & the Search for a Better Way to Deliver Primary Health Care in the U.S..

     No.4

     pp. 585-619

    Kimberly A. Parr

    Beyond Politics: A Social and Cultural History of Federal Healthcare Conscience Protections

     No.4

     pp. 620-646

    American journal of law and medicine, 2010,  Vol.36

    Author

    Title

    number

    Page to Page

    Allison Hoffman

    Oil and Water: Mixing Individual Mandates, Fragmented Markets, and Health Reform

     No.1

     pp. 7-77

    Meir Katz

    Towards a New Moral Paradigm in Health Care Delivery: Accounting for Individual

     No.1

     pp. 78-135

    Bryan A. Liang, Tim Mackey

    Confronting Conflict: Addressing Institutional Conflicts of Interest in Academic Medical Centers

     No.1

     pp. 136-187

    Freeman L. Farrow

    The Anti- Patient Psychology of Health Courts: Prescriptions from a Lawyer- Physician

     No.1

     pp. 188-219

    Jesse M. Boodoo

    Compounding Problems and Compounding Confusion: Federal Regulation of Compounded Drug Products and the FDAMA Circuit Split

     No.1

     pp. 220-247

    Anthony Gostanian

    How the FDA Can Overturn Wyeth v, Levine

     No.1

     pp. 248-268

    Robin Fretwell Wilson

    The Death of Jesse Gelsinger: New Evidence of the Influence of Money and Prestige in Human Research

     No.2-3

     pp. 295-325

    Timothy Stoltzfus Jost

    Oversight of Marketing Relationships Between Physicians and the Drug and Device Industry: A Comparative Study

     No.2-3

     pp. 326-342

    Joan H. Krause

    Following the Money in Health Care Fraud: Reflections on a Moder n- Day Yellow Brick Road

     No.2-3

     pp. 343-369

    David A. Hyman

    Follow the Money: Money Matters in Health Care, Just Like in Everything Else

     No.2-3

     pp. 370-388

    Peter D. Jacobson, Soniya Keskar Mathur

    Health Law 2010: It's Not All About the Money

     No.2-3

     pp. 389-404

    Eleanor D. Kinney

    For Profit Enterprise in Health Care: Can it Contribute to Health Reform?

     No.2-3

     pp. 405-435

    Wendy K. Mariner

    Health Reform: What's Insurance got to do with it? Recognizing Health Insurance as a Separate Species of Insurance

     No.2-3

     pp. 436-451

    Guy I. Seidman

    Is a Flat- Line a Good Thing? On the Privatization of Israel's Healthcare System

     No.2-3

     pp. 452-481

    Daniela Caruso

    Autism in the U.S.: Social Movement and Legal Change

     No.4

     pp. 483-539

    Seema K. Shah, Franklin G. Miller

    Can We Handle the Truth? Legal Fictions in the Determination of Death

     No.4

     pp. 540-585

    Marc A. Rodwin

    Patient Data: Property, Privacy and the Public Interest

     No.4

     pp. 586-618

    Stephen Pessagno

    Prometheus and Bilski: Pushing the Bounds of Patentable Subject Matter in Medical Diagnostic Techniques with the Machine- or- Transformation Test

     No.4

     pp. 619-651

    Diana Snyder

    A Reasonable Time, Place and Manner Restriction: Medicare Reimbursement Law Should Require Pharmacists to Fill Prescriptions Regardless of Personal Belief

     No.4

     pp. 652-681

    American journal of law and medicine, 2011,  Vol.37

    Author

    Title

    number

    Page to Page

    Ronen Avraham

    Clinical Practice Guidelines: The Warped Incentives in the U.S. Healthcare System

     No.1

     pp. 7-40

    Ann Marie Marciarille

    Healing Medicare Hospital Recidivism: Causes and Cures

     No.1

     pp. 41-80

    MaryBeth Musumeci

    Modernizing Medicaid Eligibility Criteria for Children with Significant Disabilities: Moving from a Disabling to an Enabling Paradigm

     No.1

     pp. 81-127

    Leslie E. Gerwin

    Planning for Pandemic: A New Model for Governing Public Health Emergencies

     No.1

     pp. 128-171

    Alana Montas

    Cheaper Clinical Trials: The Real Solution to the Biologic Industry's Gordian Knot

     No.1

     pp. 172-193

    Joanna K. Sax

    Protecting Scientific Integrity: The Commercial Speech Doctrine Applied to Industry Publications

     No.2-3

     pp. 203-224

    Aaron S. Kesselheim

    Off- Label Drug Use and Promotion: Balancing Public Health Goals and Commercial Speech

     No.2-3

     pp. 225-257

    Margaret Gilhooley

    Commercial Speech and Off- Label Drug Uses: What Role for Wide Acceptance, General Recognition and Research Incentives?

     No.2-3

     pp. 258-277

    Kate Greenwood

    The Ban on "Off- Label" Pharmaceutical Promotion: Constitutionally Permissible Prophylaxis Against False or Misleading Commercial Speech?

     No.2-3

     pp. 278-298

    David Orentlicher

    The Commercial Speech Doctrine in Health Regulation: The Clash Between the Public Interest in a Robust First Amendment and the Public Interest in Effective Protection from Harm

     No.2-3

     pp. 299-314

    Coleen Klasmeier, Martin H. Redish

    Off- Label Prescription Advertising, the FDA and the First Amendment: A Study in the Values of Commercial Speech Protection

     No.2-3

     pp. 315-357

    Christopher T. Robertson

    The Money Blind: How to Stop Industry Bias in Biomedical Science, Without Violating the First Amendment

     No.2-3

     pp. 358-387

    Nathan Cortez

    Can Speech by FDA- Regulated Firms Ever be Noncommercial?

     No.2-3

     pp. 388-421

    Amy E. Todd

    No Need for More Regulation: Payors and Their Role in Balancing the Cost and Safety Considerations of Off- Label Prescriptions

     No.2-3

     pp. 422-443

    Lia Mulligan

    You Can't Say That on Television: Constitutional Analysis of a Direct- to- Consumer Pharmaceutical Advertising Ban

     No.2-3

     pp. 444-467

    John F. Muller

    Disability, Ambivalence, and the Law

     No.4

     pp. 469-521

    Eleanor D. Kinney

    Comparative Effectiveness Research Under the Patient Protection and Affordable Care Act: Can New Bottles Accommodate Old Wine?

     No.4

     pp. 522-566

    Pamela Laufer-Ukeles

    Reproductive Choices and Informed Consent: Fetal Interests, Women's Identity, and Relational Autonomy

     No.4

     pp. 567-623

    Samuel T. Grover

    Religious Exemptions to the PPACA's Health Insurance Mandate

     No.4

     pp. 624-651

    Avalon Johnson

    Access to Elective Abortions for Female Prisoners Under the Eighth and Fourteenth Amendments

     No.4

     pp. 652-683

    American journal of law and medicine, 2012,  Vol.38

    Author

    Title

    number

    Page to Page

    Elizabeth R. Pike

    Recovering from Research: A No- Fault Proposal to Compensate Injured Research Participants

     No.1

     pp. 7-62

    Trudo Lemmens, Candice Telfer

    Access to Information and the Right to Health: The Human Rights Case for Clinical Trials Transparency

     No.1

     pp. 63-112

    Simone A. Rose

    Semiconductor Chips, Genes, and Stem Cells: New Wine for New Bottles?

     No.1

     pp. 113-157

    Glen Cheng

    The National Residency Exchange: A Proposal to Restore Primary Care in an Age of Microspecialization

     No.1

     pp. 158-195

    Johanna Ferguson

    Cure Unwanted? Exploring the Chronic Lyme Disease Controversy and Why Conflicts of Interest in Practice Guidelines May Be Guiding Us Down the Wrong Path

     No.1

     pp. 196-224

    Richard A. Epstein, Paula M. Stannard

    Constitutional Ratemaking and the Affordable Care Act: A New Source of Vulnerability

     No.2-3

     pp. 243-268

    Gary Lawson, David B. Kopel

    The PPACA in Wonderland

     No.2-3

     pp. 269-287

    Abigail R. Moncrieff

    Cost- Benefit Federalism: Reconciling Collective Action Federalism and Libertarian Federalism in the Obamacare Litigation and Beyond

     No.2-3

     pp. 288-325

    David Orentlicher

    Rights to Healthcare in the United States: Inherently Unstable

     No.2-3

     pp. 326-347

    Joel Teitelbaum, Lara Cartwright-Smith, Sara Rosenbaum

    Translating Rights into Access: Language Access and the Affordable Care Act

     No.2-3

     pp. 348-373

    Jedediah Purdy, Neil S. Siegel

    The Liberty of Free Riders: The Minimum Coverage Provision, Mill's "Harm Principle," and American Social Morality

     No.2-3

     pp. 374-396

    Marshall B. Kapp

    If We Can Force People to Purchase Health Insurance, Then Let's Force Them to Be Treated Too

     No.2-3

     pp. 397-409

    Elizabeth Weeks Leonard

    Affordable Care Act Litigation: The Standing Paradox

     No.2-3

     pp. 410-444

    B. Jessie Hill

    What Is the Meaning of Health? Constitutional Implications of Defining "Medical Necessity" and "Essential Health Benefits" Under the Affordable Care Act

     No.2-3

     pp. 445-470

    Stacey A. Tovino

    A Proposal for Comprehensive and Specific Essential Mental Health and Substance Use Disorder Benefits

     No.2-3

     pp. 471-515

    Steven J. Willis, Nakku Chung

    No Healthcare Penalty? No Problem: No Due Process

     No.2-3

     pp. 516-536

    Katherine L. Record

    Litigating the ACA: Securing the Right to Health Within a Framework of Negative Rights

     No.2-3

     pp. 537-547

    Kyle Thomson

    State- Run Insurance Exchanges in Federal Healthcare Reform: A Case Study in Dysfunctional Federalism

     No.2-3

     pp. 548-570

    Barbara J. Evans

    The Ethics of Postmarketing Observational Studies of Drug Safety Under Section 505 (o) (3) of the Food, Drug, and Cosmetic Act

     No.4

     pp. 577-606

    Kristen Underhill

    Paying for Prevention: Challenges to Health Insurance Coverage for Biomedical HIV Prevention in the United States

     No.4

     pp. 607-666

    Michelle Hottinger, Bryan A. Liang

    Deficiencies of the FDA in Evaluating Generic Formulations: Addressing Narrow Therapeutic Index Drugs

     No.4

     pp. 667-689

    Samantha Rauer

    When the First Amendment and Public Health Collide: The Court's Increasingly Strict Constitutional Scrutiny of Health Regulations that Restrict Commercial Speech

     No.4

     pp. 690-712

    David M. Ullian

    "Well Beyond" Permissible: How Severing the Leadership Act's Policy Requirement Affirms Our Commitment to First Amendment Values

     No.4

     pp. 713-741

    American journal of law and medicine, 2013,  Vol.39

    Author

    Title

    number

    Page to Page

    Sonia M. Suter

    The Politics of Information: Informed Consent in Abortion and End- of- Life Decision Making

     No.1

     pp. 7-61

    Allison K. Hoffman, Howell E. Jackson

    Retiree Out- of- Pocket Healthcare Spending: A Study of Consumer Expectations and Policy Implications

     No.1

     pp. 62-133

    Jalayne J. Arias

    A Time to Step In: Legal Mechanisms for Protecting Those with Declining Capacity

     No.1

     pp. 134-159

    Lonie Kim

    Am I Liable? The Problem of Defining Falsity Under the False Claims Act

     No.1

     pp. 160-181

    Tania Voon

    Flexibilities in WTO Law to Support Tobacco Control Regulation

     No.2-3

     pp. 199-217

    Micah L. Berman

    Commercial Speech Law and Tobacco Marketing: A Comparative Discussion of the United States and Canada

     No.2-3

     pp. 218-236

    Jane Kelsey

    The Trans- Pacific Partnership Agreement: A Gold- Plated Gift to the Global Tobacco Industry?

     No.2-3

     pp. 237-264

    Benn McGrady, Alexandra Jones

    Tobacco Control and Beyond: The Broader Implications of United States- Clove Cigarettes for Non- Communicable Diseases

     No.2-3

     pp. 265-289

    Richard Daynard

    Regulatory Approaches to Ending Cigarette- Caused Death and Disease in the United States

     No.2-3

     pp. 290-297

    Seth E. Mermin, Samantha K. Graff

    The First Amendment and Public Health, At Odds

     No.2-3

     pp. 298-307

    Matthew Allen

    Confronting the Vector of Tobacco- Related Disease

     No.2-3

     pp. 308-331

    Julien Chaisse

    Exploring the Confines of International Investment and Domestic Health Protections- Is a General Exceptions Clause a Forced Perspective?

     No.2-3

     pp. 332-360

    Jonathan Liberman

    Plainly Constitutional: The Upholding of Plain Tobacco Packaging by the High Court of Australia

     No.2-3

     pp. 361-381

    Robert Stumberg

    Safeguards for Tobacco Control: Options for the TPPA

     No.2-3

     pp. 382-441

    Lara Khoury, Marie-Eve Couture-Menard, Olga Redko

    The Role of Private Law in the Control of Risks Associated with Tobacco Smoking: The Canadian Experience

     No.2-3

     pp. 442-470

    Mark A. Levin

    Tobacco Control Lessons from the Higgs Boson: Observing A Hidden Field Behind Changing Tobacco Control Norms in Japan

     No.2-3

     pp. 471-489

    Sharona Hoffman, Andy Podgurski

    The Use and Misuse of Biomedical Data: Is Bigger Really Better

     No.4

     pp. 497-538

    Abigail R. Moncrieff

    The Individual Mandate as Healthcare Regulation: What the Obama Administration Should Have Said in NFIB v. Sebelius

     No.4

     pp. 539-572

    Jonathan F. Will

    Beyond Abortion Why the Personhood Movement Implicates Reproductive Choice

     No.4

     pp. 573-616

    Jennifer L. Pomeranz

    A Comprehensive Strategy to Overhaul FDA Authority for Misleading Food Labels

     No.4

     pp. 617- 647

    John W. Masland

    Evaluating New Hampshire's First-in-the-Nation Early Offer Alternative to Medical Malpractice Litigation

     No.4

     pp. 648-670

    Shirley S. Pan

    Closing the Gaps and Loopholes: Analyzing Tax Exemption of Non-Profit Hospital Joint Ventures after the Affordable Care Act

     No.4

     pp. 671-688

    American journal of law and medicine, 2014, Vol.40

    Author

    Title

    number

    Page to Page

    Jennifer E. Gladieux, Michael Basile

    Jimmo and the Improvement Standard Implementing Medicare Coverage through Regulations, Policy Manuals and Other Guidance

    No.1

    pp. 7-25

    Candice T. Player

    Public Assistance, Drug Testing, and the Law The Limits of Population-Based Legal Analysis

    No.1

    pp. 26-84

    Joanna Shepherd

    Combating the Prescription Painkiller Epidemic A National Prescription Drug Reporting Program

    No.1

    pp. 85-112

    Arcangelo S. Cella

    Voice in the Room The Function of State Legislative Bans on Sexual Orientation Change Efforts for Minors

    No.1

    pp. 113-140

    Lindsey Gabrielsen

    Bias at the Gate The Pharmaceutical Industry's Influence on the Federally Approved Drug Compendia

    No.1

    pp. 141-163

     

    Recent Case Developments

    No.1

    pp. 164-177

    Abigail R. Moncrieff, Manisha Padi

    Beyond Payment and Delivery Reform: The Individual Mandate's Cost-Control Potential

    No. 2-3

    pp. 185-194

    Wendy K. Mariner

    Health Insurance Is Dead; Long Live Health Insurance

    No. 2-3

    pp. 195-214

    David Auerbach

    Assessing the True Impact of the ACA: Revisiting the CBO's Initial Predictions

    No. 2-3

    pp. 231-236

    Jean C. Sullivan, Rachel Gershon

    State Fiscal Considerations and Research Opportunities Emerging from the Affordable Care Act's Medicaid Expansion

    No. 2-3

    pp. 237-252

    Benjamin D. Sommers, Sarah Gordon, Stephen Somers, Carolyn Ingram

    Medicaid on the Eve of Expansion: A Survey of State Medicaid Officials on the Affordable Care Act

    No. 2-3

    pp. 253-279

    Jeffrey Hoffmann

    Preemption and the MLR Provision of the Affordable Care Act

    No. 2-3

    pp. 280-297

    Greg Pivarnik

    Cells as Drugs: Regulating the Future of Medicine

    No. 2-3

    pp. 298-321

    Josh Archambault

    Obamacare's Impact on Labor Markets: Limits on the Predictive Value of Romneycare

    No. 2-3

    pp. 215-230

    Roy Spece, David Yokum, Andrea-Gale Okoro, Christopher Robertson

    An Empirical Method for Materiality: Would Conflict of Interest Disclosures Change Patient Decisions

    No.4

    pp. 253-274

    Kristy Lynn Williams, Marisa Finley, J. James Rohack

    Just Say No to NOTA: Why the Prohibition of Compensation for Human Transplant Organs in NOTA Should Be Repealed and a Regulated Market for Cadaver Organs Instituted

    No.4

    pp. 275-329

    William M. Janssen

    A Duty to Continue Selling Medicines

    No.4

    pp. 330-392

    Timothy D. Lytton, Barbara A. Dennison, Trang Q. Nguyen, Janine M. Jurkowski

    There Is More to Transparency than Meets the Eye: The Impact of Mandatory Disclosure Laws Aimed at Promoting Breastfeeding

    No.4

    pp. 393-415

    Jamie Lynn Flaherty

    Digital Diagnosis: Privacy and the Regulation of Mobile Phone Health Applications Notes and Comments

    No.4

    pp. 416-441

    Nina Garcia

    Starting with the Man in the Mirror: Transsexual Prisoners and Transitional Surgeries following Kosilek v. Spencer

    No.4

    pp. 442-463

     

    Recent Case Developments

    No.4

    pp. 464-476

    American journal of law and Medicine, 2015, Vol.41

    Author

    Title

    number

    Page to Page

    Elizabeth Tippett

    Medical Advice from Lawyers: A Content Analysis of Advertising for Drug Injury Lawsuits

    No.1

    pp. 7-48

    Jordan Paradise

    The Legal and Regulatory Status of Biosimilars: How Product Naming and Stats Substitution Laws May Impact the United States Healthcare System

    No.1

    pp. 49-84

    Aziza Ahmed

    Medical Evidence and Expertise in Abortion Jurisprudence

    No.1

    pp. 85-118

    Govind Persad

    Priority Setting, Cost- Effectiveness, and the Affordable Care Act

    No.1

    pp. 119-166

    Jeremy Thomas Harbaugh

    Do You Own Your 3D Bioprinted Body? Analyzing Property Issues at the Intersection of Digital Information and Biology

    No.1

    pp. 167-189

    Alexander W. Campben

    The Medical Marijuana Catch- 22: How the Federal Monopoly on Marijuana Research Unfairly Handicaps the Rescheduling Movement

    No.1

    pp. 190-209

     

    Fifth Circuit Upholds the Enforcement of Two Abortion Provisions of a Texas Act- Whole Woman's Health v. Lake

    No.1

    pp. 210-213

    Saby Ghoshray

    Genetically Modified Foods at the Intersection of the Regulatory Landscape and Constitutional Jurisprudence

    No. 2-3

    pp. 223-239

    Diana R. H. Winters

    Inappropriate Referral: The Use of Primary Jurisdiction in Food- Labeling Litigation

    No. 2-3

    pp. 240-258

    Samuel R. Wiseman

    The Implementation of the Food Safety Modernization Act and the Strength of the Sustainable Agriculture Movement

    No. 2-3

    pp. 259-273

    Paul A. Diller

    The Illusion of Autonomy in "Food" Litigation

    No. 2-3

    pp. 274-283

    Lindsay F. Wiley

    Deregulation, Distrust, and Democracy: State and Local Action to Ensure Equitable Access to Healthy, Sustainably Produced Food

    No. 2-3

    pp. 284-314

    Andrea Freeman

    Transparency for Food Consumers: Nutrition Labeling and Food Oppression

    No. 2-3

    pp. 315-330

    Christine Fry, Ian McLaughlin, Alexis Etow, Rio Holaday

    What's in Store: A Vision for Healthier Retail Environments through Better Collaboration

    No. 2-3

    pp. 331-356

    Efthimios Parasidis, Neal Hooker, Christopher T. Simons

    Addressing Consumer Confusion Surrounding "Natural" Food Claims

    No. 2-3

    pp. 357-373

    Joanna K. Sax

    Dietary Supplements are Not all Safe and Not all Food: How the Low Cost of Dietary Supplements Preys on the Consumer

    No. 2-3

    pp. 374-394

    Kathryn A. Boys, Michael Ollinger, Leon L. Geyer

    The Food Safety Modernization Act: Implications for U.S. Small Scale Farms

    No. 2-3

    pp. 395-405

    Sam F. Halabi

    The Codex Alimentarius Commission, Corporate Influence, and International Trade: A Perspective on FDA s Global Role

    No. 2-3

    pp. 406-421

    Stephen R. Miller

    A Coordinated Approach to Food Safety and Land Use Law at the Urban Fringe

    No. 2-3

    pp. 422-446

    Stephanie Tai

    Whole Foods: The FSMA and the Challenges of Defragmenting Food Safety Regulation

    No. 2-3

    pp. 447-458

    Christine Donovan

    If FDA Does Not Regulate Food, Who Will? A Study of Hormones and Antibiotics in Meat Production

    No. 2-3

    pp. 459-482

    Nicholas Falcone

    Repositioning Generics: The Comparative Value of Liability in FDA s Proposed Rule on Labeling

    No. 2-3

    pp. 483-504

     

    First Circuit Certifies Class for Third Party Payors and Individual Consumers in Pharmaceutical "Pay- For- Delay"

    No. 2-3

    pp. 505-508

     


    نظر شما



    نمایش غیر عمومی
    تصویر امنیتی :
تعداد بازدید کنندگان کل :
تا کنون :
27662293
اکنون :
28